Tag: AI in genomics


  • AI Tool to Identify Genetic Drivers of Disease: DeepMind’s AlphaGenome Unveiled

    AI Tool to Identify Genetic Drivers of Disease: DeepMind’s AlphaGenome Unveiled

    Overview: A new AI tool to map the genetic underpinnings of disease Google DeepMind has announced a cutting-edge AI tool aimed at helping researchers pinpoint the genetic drivers behind a wide range of diseases. Named AlphaGenome, the system leverages advanced machine learning to study how genetic mutations influence disease pathways, potentially accelerating the discovery of…

  • SOPHiA GENETICS Announces 2025 Results, 2026 Guidance, and CEO Transition Plan

    SOPHiA GENETICS Announces 2025 Results, 2026 Guidance, and CEO Transition Plan

    Executive Summary: Strong 2025 Close and New Growth Outlook SOPHiA GENETICS (Nasdaq: SOPH) has disclosed preliminary fourth-quarter and full-year 2025 financial results, along with guidance for 2026 and a strategic executive transition. The company underscored a solid close to 2025, highlighted by robust Q4 performance, and introduced its 2026 revenue growth target of 20-22%. In…

  • SOPHiA GENETICS Reports Strong Q4 2025, Sets 2026 Growth Path and Names New CEO

    SOPHiA GENETICS Reports Strong Q4 2025, Sets 2026 Growth Path and Names New CEO

    SOPHiA GENETICS Announces Strong Q4 2025 Performance and Full-Year Results SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI-driven genomic analytics, released preliminary fourth-quarter and full-year 2025 results that underscore the company’s momentum as it navigates a competitive bioinformatics landscape. While the company provided preliminary numbers ahead of final audited results, executives highlighted continued revenue growth,…